Nightmare Disorder | Study on the Psychotherapeutic Treatment of Chronic Nightmares
Nightmare Disorder research study
What is the primary objective of this study?
The purpose of this study is to determine whether a change in the content of nightmares is necessary at all in the treatment of chronic nightmares or if a single confrontation with their content is sufficient to reduce nightmare frequency significantly.
Who is eligible to participate?
Inclusion Criteria: - nightmare frequency of at least one night per week for six month duration - stable medication - if currently in psychotherapy: no treatment of nightmares - Informed consent Exclusion Criteria: - Life time clinical diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder according to DSM-IV - Body mass index < 17 - Initiation of nightmares after taking pharmaceuticals - Clinical diagnosis of alcohol or drug addiction according to DSM-IV - Mental retardation
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Behavioral:Imagery Rehearsal TreatmentImagery Rehearsal Therapy
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Imagery Rehearsal TreatmentImagery Rehearsal Treatment; 1 session on-site and 4 weeks of individual daily training; following principles Krakow and Zadra (2006)
ConfrontationConfrontation with nightmare content, until fear reaction habituates; 1 session on-site and 4 weeks of individual daily training
ImaginationImagination of a safe and pleasant site; 1 session on-site and 4 weeks of individual daily training
Start Date: October 2009
Completed Date: November 8, 2017
Primary Outcome: frequency of nightmares
Secondary Outcome: Anxiety
Study sponsors, principal investigator, and references
Principal Investigator: Regina Steil, PhD
Lead Sponsor: Goethe University